LCN8
Epididymal-specific lipocalin-8
Also known as: LCN5, LCN8_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6JVE9
- Gene
- LCN8
- Ensembl
- ENSG00000204001
- Chromosome
- 9
- Canonical length
- 175 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted in male reproductive system
OverviewNCBI Gene
Members of the lipocalin family, such as LCN8, have a common structure consisting of an 8-stranded antiparallel beta-barrel that forms a cup-shaped ligand-binding pocket or calyx. Lipocalins generally bind small hydrophobic ligands and transport them to specific cells (Suzuki et al., 2004 [PubMed 15363845]).[supplied by OMIM, Aug 2009]
Canonical amino-acid sequenceUniProt
175 residues, UniProt reviewed canonical sequence.
>Q6JVE9|LCN8
1 MPGAAEALPT VTVTLVAGAV PPASGALTAH CIGGFWREVG VASDQSLVLT APKRVEGLFL
61 TLSGSNLTVK VAYNSSGSCE IEKIVGSEID STGKFAFPGH REIHVLDTDY EGYAILRVSL
121 MWRGRNFRVL KYFTRSLEDK DRLGFWKFRE LTADTGLYLA ARPGRCAELL KEELILocalizationUniProt · AlphaFold · HPA
Whether an antibody against LCN8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 79 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 79 nTPM
- cerebellum: 1.8 nTPM
- thyroid gland: 0.5 nTPM
- lymph node: 0.4 nTPM
- skeletal muscle: 0.4 nTPM
- spleen: 0.3 nTPM
Single-cell type
- epididymal principal cells: 2,176 nCPM
- epididymal efferent duct absorptive cells: 435 nCPM
- epididymal efferent duct ciliated cells: 60 nCPM
- epididymal basal cells: 19 nCPM
- epididymal clear cells: 12 nCPM
- mast cells: 3.7 nCPM
Immune cell
- naive B-cell: 8.2 nTPM
- memory B-cell: 4.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebellum: 1.8 nTPM
- cerebral cortex: 0.2 nTPM
- hypothalamus: 0.2 nTPM
- basal ganglia: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
- midbrain: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.21
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.02
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LCN8 as an antibody target. Whether an autoantibody or antibody against LCN8 could matter depends on whether native LCN8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LCN8 is annotated as secreted, so native LCN8 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label LCN8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...